Alexandre de Figueiredo1, Iain G Johnston2, David M D Smith3, Sumeet Agarwal4, Heidi J Larson5, Nick S Jones6. 1. Department of Mathematics, Imperial College London, London, UK. 2. Department of Mathematics, Imperial College London, London, UK; School of Biosciences, University of Birmingham, Birmingham, UK. 3. London School of Hygiene & Tropical Medicine, London, UK. 4. Department of Electrical Engineering, Indian Institute of Technology, New Delhi, India. 5. London School of Hygiene & Tropical Medicine, London, UK; Department of Global Health, University of Washington, Seattle, WA, USA. Electronic address: heidi.larson@lshtm.ac.uk. 6. Department of Mathematics, Imperial College London, London, UK. Electronic address: nick.jones@imperial.ac.uk.
Abstract
BACKGROUND: Incomplete immunisation coverage causes preventable illness and death in both developing and developed countries. Identification of factors that might modulate coverage could inform effective immunisation programmes and policies. We constructed a performance indicator that could quantitatively approximate measures of the susceptibility of immunisation programmes to coverage losses, with an aim to identify correlations between trends in vaccine coverage and socioeconomic factors. METHODS: We undertook a data-driven time-series analysis to examine trends in coverage of diphtheria, tetanus, and pertussis (DTP) vaccination across 190 countries over the past 30 years. We grouped countries into six world regions according to WHO classifications. We used Gaussian process regression to forecast future coverage rates and provide a vaccine performance index: a summary measure of the strength of immunisation coverage in a country. FINDINGS: Overall vaccine coverage increased in all six world regions between 1980 and 2010, with variation in volatility and trends. Our vaccine performance index identified that 53 countries had more than a 50% chance of missing the Global Vaccine Action Plan (GVAP) target of 90% worldwide coverage with three doses of DTP (DTP3) by 2015. These countries were mostly in sub-Saharan Africa and south Asia, but Austria and Ukraine also featured. Factors associated with DTP3 immunisation coverage varied by world region: personal income (Spearman's ρ=0·66, p=0·0011) and government health spending (0·66, p<0·0001) were informative of immunisation coverage in the Eastern Mediterranean between 1980 and 2010, whereas primary school completion was informative of coverage in Africa (0·56, p<0·0001) over the same period. The proportion of births attended by skilled health staff correlated significantly with immunisation coverage across many world regions. INTERPRETATION: Our vaccine performance index highlighted countries at risk of failing to achieve the GVAP target of 90% coverage by 2015, and could aid policy makers' assessments of the strength and resilience of immunisation programmes. Weakening correlations with socioeconomic factors show a need to tackle vaccine confidence, whereas strengthening correlations point to clear factors to address. FUNDING: UK Engineering and Physical Sciences Research Council.
BACKGROUND: Incomplete immunisation coverage causes preventable illness and death in both developing and developed countries. Identification of factors that might modulate coverage could inform effective immunisation programmes and policies. We constructed a performance indicator that could quantitatively approximate measures of the susceptibility of immunisation programmes to coverage losses, with an aim to identify correlations between trends in vaccine coverage and socioeconomic factors. METHODS: We undertook a data-driven time-series analysis to examine trends in coverage of diphtheria, tetanus, and pertussis (DTP) vaccination across 190 countries over the past 30 years. We grouped countries into six world regions according to WHO classifications. We used Gaussian process regression to forecast future coverage rates and provide a vaccine performance index: a summary measure of the strength of immunisation coverage in a country. FINDINGS: Overall vaccine coverage increased in all six world regions between 1980 and 2010, with variation in volatility and trends. Our vaccine performance index identified that 53 countries had more than a 50% chance of missing the Global Vaccine Action Plan (GVAP) target of 90% worldwide coverage with three doses of DTP (DTP3) by 2015. These countries were mostly in sub-Saharan Africa and south Asia, but Austria and Ukraine also featured. Factors associated with DTP3 immunisation coverage varied by world region: personal income (Spearman's ρ=0·66, p=0·0011) and government health spending (0·66, p<0·0001) were informative of immunisation coverage in the Eastern Mediterranean between 1980 and 2010, whereas primary school completion was informative of coverage in Africa (0·56, p<0·0001) over the same period. The proportion of births attended by skilled health staff correlated significantly with immunisation coverage across many world regions. INTERPRETATION: Our vaccine performance index highlighted countries at risk of failing to achieve the GVAP target of 90% coverage by 2015, and could aid policy makers' assessments of the strength and resilience of immunisation programmes. Weakening correlations with socioeconomic factors show a need to tackle vaccine confidence, whereas strengthening correlations point to clear factors to address. FUNDING: UK Engineering and Physical Sciences Research Council.
Authors: Sara Cooper; Bey-Marrié Schmidt; Evanson Z Sambala; Alison Swartz; Christopher J Colvin; Natalie Leon; Charles S Wiysonge Journal: Cochrane Database Syst Rev Date: 2021-10-27
Authors: Jonathan F Mosser; William Gagne-Maynard; Puja C Rao; Aaron Osgood-Zimmerman; Nancy Fullman; Nicholas Graetz; Roy Burstein; Rachel L Updike; Patrick Y Liu; Sarah E Ray; Lucas Earl; Aniruddha Deshpande; Daniel C Casey; Laura Dwyer-Lindgren; Elizabeth A Cromwell; David M Pigott; Freya M Shearer; Heidi Jane Larson; Daniel J Weiss; Samir Bhatt; Peter W Gething; Christopher J L Murray; Stephen S Lim; Robert C Reiner; Simon I Hay Journal: Lancet Date: 2019-04-05 Impact factor: 79.321
Authors: Heidi J Larson; Alexandre de Figueiredo; Zhao Xiahong; William S Schulz; Pierre Verger; Iain G Johnston; Alex R Cook; Nick S Jones Journal: EBioMedicine Date: 2016-09-13 Impact factor: 8.143
Authors: Elizabeth Cecil; Alex Bottle; Richard Ma; Dougal S Hargreaves; Ingrid Wolfe; Arch G Mainous; Sonia Saxena Journal: BMC Med Date: 2018-09-17 Impact factor: 8.775